Skip to main content
Top
Published in: Archives of Dermatological Research 3/2023

20-10-2022 | Stevens-Johnson Syndrome | Short Report

Pediatric Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: a national analysis of 2016 Kids’ Inpatient Database

Authors: Julianne M. Falotico, Amar D. Desai, Shari R. Lipner

Published in: Archives of Dermatological Research | Issue 3/2023

Login to get access

Abstract

Pediatric-specific studies on Stevens–Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are lacking. The objective of this study was to characterize demographics, comorbidities, and outcomes of pediatric SJS and TEN patients on a national level. On average, pediatric SJS/TEN patients were hospitalized longer and had higher mortality rates compared to reports in most previous studies. Better access to dermatologic and multidisciplinary care may help improve pediatric outcomes, although these findings must be corroborated in future studies on larger pediatric populations with SJS and TEN.
Appendix
Available only for authorised users
Literature
1.
go back to reference Antoon JW, Goldman JL, Lee B et al (2018) Incidence, outcomes, and resource use in children with Stevens-Johnson syndrome and toxic epidermal necrolysis. Pediatr Dermatol 35(2):182–187CrossRefPubMed Antoon JW, Goldman JL, Lee B et al (2018) Incidence, outcomes, and resource use in children with Stevens-Johnson syndrome and toxic epidermal necrolysis. Pediatr Dermatol 35(2):182–187CrossRefPubMed
2.
go back to reference Hsu DY, Brieva J, Silverberg NB et al (2017) Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States. J Am Acad Dermatol 76(5):811–817CrossRefPubMedPubMedCentral Hsu DY, Brieva J, Silverberg NB et al (2017) Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States. J Am Acad Dermatol 76(5):811–817CrossRefPubMedPubMedCentral
3.
go back to reference Ramien M, Goldman JL (2020) Pediatric SJS-TEN: where are we now? F1000Res 9:982–993.CrossRef Ramien M, Goldman JL (2020) Pediatric SJS-TEN: where are we now? F1000Res 9:982–993.CrossRef
4.
go back to reference Quirke KP, Beck A, Gamelli RL et al (2015) A 15-year review of pediatric toxic epidermal necrolysis. J Burn Care Res 36(1):130–136CrossRefPubMed Quirke KP, Beck A, Gamelli RL et al (2015) A 15-year review of pediatric toxic epidermal necrolysis. J Burn Care Res 36(1):130–136CrossRefPubMed
5.
go back to reference Finkelstein Y, Soon GS, Acuna P et al (2011) Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Pediatrics 128(4):723–728CrossRefPubMed Finkelstein Y, Soon GS, Acuna P et al (2011) Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Pediatrics 128(4):723–728CrossRefPubMed
6.
go back to reference Messenger E, Kovarik CL, Lipoff JB (2016) Access to inpatient dermatology care in Pennsylvania hospitals. Cutis 97(1):49–51PubMed Messenger E, Kovarik CL, Lipoff JB (2016) Access to inpatient dermatology care in Pennsylvania hospitals. Cutis 97(1):49–51PubMed
Metadata
Title
Pediatric Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: a national analysis of 2016 Kids’ Inpatient Database
Authors
Julianne M. Falotico
Amar D. Desai
Shari R. Lipner
Publication date
20-10-2022
Publisher
Springer Berlin Heidelberg
Published in
Archives of Dermatological Research / Issue 3/2023
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-022-02414-3

Other articles of this Issue 3/2023

Archives of Dermatological Research 3/2023 Go to the issue